https://pubmed.ncbi.nlm.nih.gov/36934840/ PFIC

Gastroenterol Hepato. 2023 Mar 17;S0210-5705(23)00064-X.
doi: 10.1016/j.gastrohep.2023.03.001. Online ahead of print.

Expression of miR-let7b and miR-19b in Progressive familial intrahepatic cholestasis (PFIC) children

[Article in English, Spanish]

Mahintaj Dara 1, Negar Azarpira 2, Nasrin Motazedian 3, Mahdokht Hossein-Aghdaie 3, Seyed-Mohsen Dehghani 3, Bita Geramizadeh 4, Elaheh Esfandiari 3

Abstract

Background: MicroRNAs (miRNAs) are a group of small non-coding RNAs that bind to the target mRNA and regulate gene expression. Recently circulating microRNAs were investigated as markers of diseases and therapeutic targets. Although various studies analyze the miRNA expression in liver disease, these studies on PFIC are few. Progressive familial intrahepatic cholestasis (PFIC) is a rare liver disease with autosomal recessive inheritance. Most children with PFIC progress to cirrhosis and liver failure and consequently need to have a liver transplant. The aim of this study is the investigation of the miR-19b and miR-let7b expression levels in Iranian PFIC children.

Methods: 25 PFIC patients, 25 healthy children and 25 Biliary Atresia patients were considered as case and two control groups respectively. Blood samples were obtained and Liver function tests (LFTs) were measured. After RNA extraction and cDNA synthesis, quantitative PCR was performed using specific primers for miR-19b and miR-let7b. The U6 gene is used as an internal control.

Results: qPCR on PFIC patients' samples demonstrated that the miR-19b and the miR-let7b expression were significantly decreased in patients compared to the control groups, with a p-value < 0.0001 and p-value=0.0006 receptively.
Conclusion: In conclusion, circulating micro-RNA like miR-19b and miR-let7b have a potential opportunity to be a non-invasive diagnostic marker or therapeutic target for PFIC in the future.